Is Inhibrx Biosciences, Inc. (INXB) a Buy, Sell, or Hold?
NASDAQ : INXB
Inhibrx Biosciences, Inc.
$15.86 USD
$1.94 (13.94%)
- Volume
- 725.34K
- Average Volume
- 507.57K
- Market Capitalization
- $225.87M
- P/E Ratio
- -10.42
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $18.95
- Year Low
- $12.95
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.46
INXB vs. The Competition
| Properties | INXB | CATB | CBLI | CELU |
|---|---|---|---|---|
| Market Cap | $225.87M | $234.86M | $226.39M | $18.77M |
| Shares Outstanding | $14.24M | $27.5M | $71.42M | $24.05M |
| P/E Ratio | -10.42 | -5.02 | -16.68 | -0.21 |
| EPS | -8.35 | 0 | -0.19 | -3.58 |
| Day Low | 13.85 | 8.48 | 3.11 | 0.75 |
| Day High | 15.99 | 9.21 | 3.5 | 0.8436 |
| Year Low | 12.95 | 1.25 | 2.7 | 0.56 |
| Year High | 18.95 | 10.26 | 5.64 | 4.35 |
| Average Price 50 | 16.453636 | 8.228566 | 3.5693333 | 0.798 |
| Average Price 200 | 16.453636 | 3.7395024 | 3.5693333 | 1.31172 |
| Volume | 725.34K | 98872 | 116.26K | 16234 |
| Average Volume | - | - | - | - |